In TNBC, IL-8 also recruits myeloid-derived suppressor cells (MDSCs), supporting stemness [47], and upregulates breast cancer resistance proteins, contributing to doxorubicin resistance [48]. The gene discussed is CXCL8; the disease is breast cancer.